Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Safeture plans to sell Travelogix to focus on core enterprise offering

Safeture AB (ticker: SFTR) (“Safeture”) today announced that it has signed an agreement to sell its 51 percent holding in the U.K.-based travel software company Travelogix Limited (“Travelogix”) to the firm’s management team for 375,000 GBP (about 4.4 million SEK) to be paid in cash upon closing of the transaction. Safeture will use the proceeds from the sale to reinvest in its core Enterprise offering. Since the shares are sold to the management team in Travelogix, closing of the transaction is conditional upon Safeture shareholders approving the transaction at an extraordinary general

100 TetraGraph systems to Japan after regulatory approval

Press release: Uppsala, August 30, 2019. In December 2016, Senzime AB (publ) signed a ten-year licensing agreement with Japanese Fukuda Denshi on the exclusive right to license and commercialize Senzime's TetraGraph system in the Japanese market. Fukuda are now about to initiate market launch as TetraGraph has obtained regulatory approval from the Japanese authorities. At the same time, Senzime receives a milestone payment of approximately SEK 1.8 million and 100 TetraGraph systems are shipped to Japan. Fukuda Denshi Co. Ltd (Fukuda) is a world leader in the patient monitoring

Interim report 2019-01-01 – 2019-06-30

The Board and Chief Executive Officer of Cereno Scientific AB here with present the interim report for the second quarter 2019.Summary of the interim report  Six months (1 January 2019 – 30 June 2019) · Net sales were SEK 0 (0). · Loss after financial items was SEK -8,585,551 (-4,908,504). · Loss per share was SEK -0.30 (-0.45) before dilution and SEK -0.28*(-0.42) after dilution. · The equity/assets ratio was 94.7% (59.2%). Three months (1 April 2019 – June 30, 2019) · Net sales were SEK 0 (0). · Loss after financial items was SEK -3,251,918 (-3,103,061). ·

Interim Report For FluoGuide, Second Quarter 2019

FluoGuide today publishes its interim report for the period January - June 2019Andreas Kjær, responsible for research of FluoGuide comments: "I am very pleased that promising data on the benefit of FG001 in glioblastoma and pancreatic cancer have been selected for presentation at WMIC, an important society within molecular imaging and surgical guidance. Optical targeting of uPAR is likely to become of benefit to patients and surgeons in several cancer indications and this presentation is an important event to highlight the technology’s potential." Morten Albrechtsen, CEO of FluoGuide

C-RAD AB – Interim report January-June 2019

C-RAD AB – Interim report January-June 2019 RECORD HIGH ORDER BACK LOG JANUARY - JUNE 2019  · Order intake: 64.1 (56.4) MSEK · Order backlog: 214,5 (156,5) MSEK · Revenues: 51.5 (51.9) MSEK · EBITDA: 1.9 (3.1) MSEK · Operating profit: -0.6 (2.0) MSEK   · Net results after tax: -0.9 (1.6) MSEK · Result per share: -0.03 (0.05) SEK · C-RAD and OPASCA announce strategic partnership · Peter Eidensjö leaves C-RAD´s board of directors.   Presentation of the interim reportCEO Tim Thurn and CFO Therése Björklund will present the interim report byWebcast

HIDDN – Financial results for the second quarter of 2019

Enclosed please find Hiddn Solutions ASA’s report for the second quarter of 2019.Important events in the second quarter of 2019 and year-to date · Significant changes in the Group’s operations The subsidiary, Hiddn Security AS, reported lower operating revenue than budgeted and continued loss making during first quarter of 2019. This negative trend increased in second quarter of 2019.   A new assessment of future sales and probabilities to find bases for a profit-making business was performed. The conclusion from the assessment was that this would involve unacceptable risk and call

New updated data will be presented from Oncopeptides’ Pivotal Phase 2 HORIZON study in patients with extra medullary disease (EMD) on September 15th

Stockholm - 30 August 2019 - Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that new updated melflufen data from the Phase 2 pivotal OP-106 HORIZON study will be presented at at the 17th International Myeloma Workshop (IMW) meeting on September 15, Boston, Massachusetts, USA. These data are from at later data cut compared with previously presented data at EHA in June or in the abstract book for IMW.In conjuction with the presentation the new data will be available on the company webpage under: www.oncopeptides.com  /

Bulten appoints new Senior Vice President Production

Bulten has appointed Fredrik Bäckström as new Senior Vice President Production. He takes up the position on December 1, 2019 and will be a member of Bulten’s Executive Management Team. Fredrik succeeds Jörg Neveling, who will retire on October 31, 2019.Fredrik Bäckström, born in 1965, holds an M.Sc. in Mechanical Engineering. He has previously held several leading positions within Poseidon Diving System AB, Carmel Pharma AB, Pågen/Pååls Bakery and Dayco Automotive AB amongst others. Fredrik joins Bulten from Arcam AB where he has been Vice President Product Supply since 2013. ”I am very

Flexion Mobile signs distribution agreement with Xiaomi

LONDON, 30th of Aug, 2019 – Flexion Mobile Plc (Nasdaq: FLEXM) , the London-based Android games distribution company today announced that it has signed an agreement with Xiaomi, the 3rd biggest Android device manufacturer in the world. Xiaomi operates one of the biggest app stores in China and is currently rolling out the store in its strongest overseas markets. The agreement means that Flexion will integrate the "GetApps" branded app store into its distribution network and start distributing its game portfolio to Xiaomi users outside China. “Our distribution

Q2 2019 Interim financial report North Investment Group AB (publ)

Highlights · Group revenue of SEK 225m during the quarter comprising growth of 22.9% (+2.8% proforma 2018 incl Sørlie). Robust commercial development across most business areas. · EBITDA of SEK 15.0m in Q2 (SEK 16.0m). · Unrealized foreign exchange loss 1H 2019 of SEK 5.3m (SEK 1.1m gain 1H 2018). · Appointment of Ole Vinje as CEO, effective from 1st of September. · Integration of Sørlie Prosjektinnredninger continues at full strength. · The Agentur for Fossafe products in Norway taken over in June. · Order backlog of SEK 155m per Q2 2019 (SEK 136m Q2 2018). Key

New number of shares in Handelsbanken

Due to an exchange of convertible notes in Svenska Handelsbanken AB, the number of Class A shares has increased by 267 639 shares and the number of votes has increased by 267 639.Following the increase, the total number of shares in Handelsbanken is 1 955 285 447 of which 1 920 034 118 are Class A shares and 35 251 329 are Class B shares. The total number of votes in Handelsbanken is 1 923 559 250,9.The share capital amounts to SEK 3 030 692 442,85 after the increase.For further information, please contact:Lars Höglund, Head of Investor Relations: +46 8–701 51 70,+46 70–345 51 70

SKF makes Group Management appointment

Göteborg, 30 augusti 2019: SKF har utsett Thomas Fröst till ny medlem i koncernledningen från och med 1 september 2019. Thomas har sedan 2017 innehaft positionen President, Industrial Units. I samband med utnämningen kommer hans ansvarsområde att byta namn till Industrial Technologies. Dessa förändringar återspeglar den strategiska betydelsen att fortsatt integrera alla aspekter av SKFs lösningar, inklusive tätningar och smörjsystem, i koncernens kunderbjudande. Thomas började arbeta på SKF 1988 och har haft olika ledande positioner, inklusive Head of Industrial Seals, Marine och

Change of number of shares and votes in Enea

Stockholm, Sweden, August 30, 2019 Enea® (Nasdaq Stockholm: ENEA) As previously announced, Enea AB (publ) (“Enea”) has made a directed issue of 1,965,000 shares to qualified investors at a subscription price of SEK 138 per share (for further information, see Enea’s press releases on 22 and 23 August 2019). As a result thereof, the number of shares and votes in Enea has changed and amounts today, the last trading day of the month, to 21,615,231. This is information that Enea AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The

GomSpace (provider of nanosatellites) announces its quarterly results for the second quarter 2019

GomSpace Group AB (the “Company”) announces its interim report for the second quarter of 2019. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: Second quarter summary 1 April – 30 June 2019 (2018) · Order intake increased to T.SEK 61,719 (30,072), an increase of 105% · Net revenues increased to T.SEK 52,224 (41,821), an increase of 25% · Gross margin decreased to 23% (28%) · Operating profit (loss) decreased to a negative T.SEK 42,328 (a negative 26,637) · Earnings per share were a negative SEK 0.

Hansa Biopharma: New imlifidase data presented at ESOT, Copenhagen

Lena Winstedt, PhD, Head of Science at Hansa Biopharma, will present results from a pooled analysis of Phase 2 trials with imlifidase for desensitization in sensitized kidney transplant patients.Lund, Sweden August 30, 2019. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that new imlifidase data will be highlighted in a presentation at the 19th Congress of the European Society for Organ Transplantation (ESOT), taking place September 15 to 18, 2019 in Copenhagen, Denmark.In an oral poster session on Tuesday, September 17,

Scout Gaming publishes Q2 2019: Increased revenues for the start of H2

”We continue to build long-term values through agreements we entered into during the quarter, integrations we have made, as well as the products we have completed and started to launch with our partners. The effect of spring's work has as anticipated, started to have an effect after the summer in connection to the start of the major sport leagues. We have previously been somewhat behind schedule, but have caught up after the end of the quarter and are now in line with expectations of achieving a solid revenue growth during the second half of 2019. The network effect is now starting to get

Interim report for the period 1 January – 30 June, 2019

EWPG Holding AB (publ) reports significant progress during the first two quarters of 2019EWPG Holding AB (publ) (the “Company”, “Eco Wave Power” or “EWP”) secures multiple grants; establishes subsidiary in Australia; enters joint venture with EDF Renewables; significantly expands projects pipe line; presents new patents approval for registration; and wins multiple awards for EWP’s work, including inclusion in the SET100 list of energy companies which are revolutionizing the world by DENA and the World Energy CouncilComments to the financialsNumbers in parentheses refers to outcomes

ZINZINO AB (PUBL): INTERIM REPORT Q2 2019

ZINZINO UPGRADES THE SALESFORCASTStrong growth in Central Europe combined with good development in most other markets contributed to total revenues increasing by 23% to SEK 179.5 (145.5) million in the second quarter. During the quarter, a successful launch in Australia was completed and the rapidly rising number of customers and distributors in the market is now establishing a local office in Adelaide. In addition, Zinzino has launched the new product Essent, the next-generation capsule-based dietary supplement in Omega-3, a new and very important product for the North American market.

Essity and UNICEF in Mexico strengthen collaboration on hygiene issues

Essity and UNICEF in Mexico have entered into a new agreement to jointly promote awareness of the importance of good hand hygiene and to break the taboos around menstruation. Over the next three years, the collaboration will provide education to 4,000 pupils and 500 teachers in Mexico City and Chihuahua about attitudes and habits in connection with menstrual hygiene management and hand washing.The project is called Hygiene is our right, and highlights the rights of children and young people in relation to health, education and gender equality. The shortage of water and hygiene facilities in

Stillfront resolves to allot subscribed shares to the sellers of each of Imperia Online, eRepublik and Babil Games

Stillfront resolves to allot the subscribed shares in the new issues of shares to the sellers of Imperia Online JSC, eRepublik Labs. Limited and Babil Games FZ LLC respectively. Imperia The general meeting in Stillfront Group AB (publ) (“Stillfront” or the “Company”) resolved on 9 May 2019 on a directed new share issue of not more than 120,336 shares to the sellers of Imperia Online JSC (“Imperia”), which shall constitute part of the earn-out consideration to be paid following the Company’s acquisition of all of the shares in Imperia 2018. The earn-out consideration, which shall be

INTERNATIONELLA ENGELSKA SKOLAN YEAR-END REPORT, 1 JULY-30 JUNE 2018/2019

Fourth quarter (April-June) · Operating income increased by 23.7% to MSEK 756.5 (611.4), of which organic growth amounted to 14.3% · The number of students in the Swedish operation at the end of the quarter was 25,536 (23,927) · The number of registrations in the queue in Sweden at the end of the quarter was about 191,700 (190,000) · Operating profit (EBIT) rose 155.4% to MSEK 71.0 (27.8) · The operating margin was 9.4% (4.5) · Profit for the quarter totalled MSEK 54.3 (19.5) · Earnings per share were SEK 1.35 (0.49) · Cash flow for the quarter was MSEK 68.3 (-123.

Q2 Interim report January – June 2019

JANUARY – JUNE 2019 (COMPARED WITH JANUARY – JUNE 2018)· Revenue increased by 0.5% to SEK 224.8 million (223.7) · Net interest income increased by 2.8% to SEK 152.5 million (148.3) · Profit before tax (EBT) decreased by 22% to SEK 69.3 million (88.9) · Cost/income ratio increased to 0.28 (0.23) · The return on equity was 30% “During the second quarter, we converted to IFRS that together with other strategic investments are important steps towards realizing our vision of becoming a challenger neo-bank with an international presence. We have also introduced the second product

WntResearch increases resources for out-licensing of Foxy-5

WntResearch and The Sage Group have initiated a collaboration to accelerate the process of identifying and engaging potential partners prior to readout of the on-going Phase 2 study with Foxy-5.Cancer is by far the largest research area in the pharmaceutical industry and the number of companies focusing on developing and commercializing new cancer treatments amounts to several thousands. In order to increase the visibility of Foxy-5 and engage companies with the right focus and interest in a discussion about a potential future partnership, WntResearch has chosen to start a collaboration

Panoro Encounters Hydrocarbons at Hibiscus Updip Prospect

Oslo, 30 August 2019 – Panoro Energy ASA (the “Company” or “Panoro” with OSE ticker: “PEN”) is pleased to announce that the Hibiscus Updip well (“DHIBM-1”), currently being drilled on the Dussafu Marin Permit (“Dussafu”) offshore Gabon, has encountered hydrocarbons.  Logging operations and evaluation of the oil discovery are currently underway, following which Panoro expects a side-track of DHIBM-1 to be drilled. Further updates will be provided following completion of these activities.

There are no items matching the current filter
There are no more items matching the current filter
Back to top